Clinical, laboratory, and radiological characteristics of lung damage in pediatric patients hospitalized with bronchial asthma and bronchiectasis

Undiagnosed comorbid conditions are a common cause of difficulty in achieving control of bronchial asthma (BA). One of the comorbid conditions in asthma is bronchiectasis (BE).

Objective. To characterize clinical, laboratory, and radiological features of lung damage in children hospitalized for asthma and BE.

Materials and methods. Patients with asthma and BA were observed at the Morozovskaya Children’s City Clinical Hospital from January 2023 to July 2025. The criteria for inclusion in the study were pediatric age, confirmed asthma, and the presence of BE unrelated to cystic fibrosis. The following diagnostic tools were used: analysis of clinical history, allergology and immunology tests, radiography, thoracic computed tomography, fiberoptic bronchoscopy with microbiological examination of bronchoalveolar lavage fluid, pulmonary function test, as well as the study of ciliary motility, and genetic tests.

Results. In the period from January 1, 2023 to July 1, 2025 19 children with asthma and BE admitted to the Department of Pulmonology at the Morozovskaya Children’s City Clinical Hospital accounted for 1,4% of all children with asthma hospitalized during this period (19/1392). There were 10 (53%) male patients with asthma and BE; at the moment of admission, the median age of patients was 9.0 [7.0; 11.0] years; the median age at the onset of asthma was 1,5 [0.54; 2.0] years, asthma duration was 8,0 [5.5; 10.0] years, while the median length diagnostic delay was 5,5 [2.75; 8.5] years. Upon admission, 17 (89%) children reported a decrease in exercise tolerance, 15 (79%) — shortness of breath, 10 (53%) — dry cough; 6 (32%) patients had dry wheezing, 3 (16%) — wheezing. The levels of eosinophils and monocytes were respectively 0,22 [0.07; 0.34] and 0,42 [0.33; 0.46] cl/ml; median forced expiratory volume in 1 sec. was 80,0 [47.0; 89.0]%. A positive family history of allergy was present in 12 (63%) patients, concomitant allergic rhinitis in 10 (53%), and atopic dermatitis in 6 (32%). Primary ciliary dyskinesia was confirmed in 2 (11%) patients, while atopic asthma prevailed in 15 (79%), and non-atopic asthma in 4 (21%). At the time of enrollment, 13 (68%) patients had moderate asthma, 3 (16%) mild asthma, and 3 (16%) severe asthma; 6 (32%) patients had partially controlled asthma, and 4 (21%) uncontrolled asthma; 10 (53%) patients were hospitalized for asthma exacerbation. Chest CT scans revealed BE in the middle lobe of the right and/or lingual segments of the left lung in 13 (69%) patients, while 14 (74%) patients had traction BE. The majority of patients (13/16) had purulent endobronchitis. The most common pathogen detected in the culture of bronchoalveolar lavage fluid was H. influenzae.

Conclusion. A single-center study was conducted to characterize the clinical, laboratory and radiological outcomes in pediatric patients hospitalized with asthma and BA.

1. Global Initiative for аsthma (GINA): Global strategy for asthma management and prevention. 2025. URL: http://www.ginasthma.org [Accessed 01.09.2025].

2. Bronchial asthma. Clinical guidelines 2024. Russian Association of Allergologists and Clinical Immunologists. Russian Respiratory Society. The Union of Pediatricians of Russia. 2024–2026. (In Russ.). URL: https://cr.minzdrav.gov.ru/view-cr/359_3 [Accessed 09/01/2025].

3. Ovsyannikov D.Yu., Furman E.G., Eliseeva T.I. Bronchial asthma in children: the monograph. Edited by D. Y. Ovsyannikov. Moscow: RUDN University, 2019:211. (In Russ.).

4. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. doi: 10.1016/S0140-6736(20)30925-9.

5. Asher M.I., Bissell K, Beasley R et al. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. Lancet. 2021;398(10311):1569–1580. doi: 10.1016/S0140-6736(21)01450-1.

6. Ovsyannikov D.Yu., Eliseeva T.I., Khaled M., and others. Comorbidity of bronchial asthma in children: causal, complicated, unspecifi ed, reverse. Pediatrics named aft er G.N. Speransky. 2021;100(2):127–137. (In Russ.). doi: 10.24110/0031-403X-2021-100-2-127-137.

7. Frolov P.A., Zhestkova M.A., Ovsyannikov D.Yu. Modern concepts of bronchiectasis in children. Tuberculosis and lung diseases. 2022;100(7):59–66. (In Russ.). doi: 10.21292/2075-1230-2022-100-7-59-66.

8. Chang A.B., Fortescue R, Grimwood K et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J. 2021;58(2):2002990. doi: 10.1183/13993003.02990-2020.

9. Frolov P.A., Zhestkova M.A., Ovsyannikov D.Yu., and others. Bronchiectasis not associated with cystic fi brosis in children: etiological structure, clinical, laboratory and computed tomographic characteristics. Pediatrics. Consilium Medicum. 2022;2:166–173. (In Russ.). doi: 10.26442/26586630.2022.2.201679.

10. Crimi C., Ferri S., Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol. 2019;19(1):46–52. doi: 10.1097/ACI.0000000000000492.

11. Crimi C., Ferri S., Campisi R. et al. Th e Link between Asthma and Bronchiectasis: State of the Art. Respiration. 2020;99(6):463–476. doi: 10.1159/000507228.

12. Rational therapy of bronchial asthma. A guide for doctors. Edited by A.V. Yemelyanov. Moscow: GEOTAR-Media, 2025:246–249. (In Russ.).

13. Ma D., Cruz M.J., Ojanguren I. et al. Risk factors for the development of bronchiectasis in patients with asthma. Sci Rep. 2021;11(1):22820. doi: 10.1038/s41598-021-02332-w.

14. Carpagnano G.E., Quaranta V.N., Crimi C. et al. Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers. J. Respir. 2023;3:178–190. doi:10.3390/jor3040017.

15. Bacharier L.B., Boner A., Carlsen K.H. et al. Diagnosis and treatment of asthma in childhood: A PRACTALL consensus report. Allergy. 2008;63(1):5–34. doi: 10.1111/j.1398-9995.2007.01586.x.

16. Juniper E.F., O’Byrne P.M., Guyatt G.H. et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999;14:902–907. doi: 10.1034/j.1399-3003.1999.14d29.x.

17. Nathan R.A., Sorkness C.A., Kosinski M.. et al. Development of the asthma control test: a survey for assessing asthma control. J. Allergy Clin. Immunol. 2004;113:59–65. doi: 10.1016/j.jaci.2003.09.008.

18. Reddel H.K., Taylor D.R., Bateman E.D. et al. American Th oracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An offi cial American Th oracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi: 10.1164/rccm.200801-060ST.

19. Spirometry: methodological recommendations. Russian Respiratory Society, Russian Association of Functional Diagnostics Specialists, Russian Scientifi c Medical Society of Th erapists. 2023: 106. (In Russ.). URL: https://www.pulmonology.ru/publications/spirometriya-metodicheskie-rekomendatsii-2023 [date accessed: 09/01/2025].

20. Agarwal R., Sehgal I.S., Muthu V. et al. Revised ISH-AM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses. Eur Respir J. 2024;63(4):2400061. doi: 10.1183/13993003.00061-2024.

21. Lucas J.S., Barbato A., Collins S.A. et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur. Respir. J. 2016;19(1):1–26. doi: 10.1183/13993003.01090-2016.

22. Frolov P.A., Kolganova N.I., Ovsyannikov D.Yu., et al. Possibilities of early diagnosis of primary ciliary dyskinesia. Speransky Pediatrics. 2022;101(1):107–114. (In Russ.). doi: 10.24110/0031-403X-2022-101-1-107-114.

23. Strelnikova V.A., Ovsyannikov D.Yu., Pushkov A.A., et al. Primary ciliary dyskinesia in children: clinical, laboratory, instrumental, and genetic characteristics. Pediatrics. Consilium Medicum. 2024;2:280–288. (In Russ.). doi: 10.26442/26586630.2024.3.202914.

24. Shapiro A.J., Ferkol T.W. Nelson Textbook of Pediatrics / ed. by R.M. Kliegman et al. 21st ed. Philadelphia : Elsevier. 2020:2230–2234.

25. Levine H., Bar-On O., Nir V. et al. Reversible Bronchial Obstruction in Primary Ciliary Dyskinesia. J Clin Med. 2022;11(22):6791. doi: 10.3390/jcm11226791.

26. Owora A., Gaston B., Marozkina N. Asthma in primary ciliary dyskinesia: A local airway response rather than a feature of systemic allergic response. European Respiratory Journal. 2024;64(68):PA3139.

27. Zein J., Owora A., Kim H.J. et al. Asthma Among Children With Primary Ciliary Dyskinesia. JAMA Netw Open. 2024;7(12):e2449795. doi: 10.1001/jamanetworko-pen.2024.49795.